Cell-penetrating peptide PEP-1-mediated transduction of enhanced green fluorescent protein into human umbilical vein endothelial cells

Acta Academiae Medicinae Sinicae

Volumn 29, Issue 1, 2007, Pages 93-97

  Dong, Xiao ^a   Wang, Jia Ning ^a   Huang, Yong Zhang ^a   Guo, Ling Yun ^a   Kong, Xia ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cell penetrating peptide; Enhanced green fluorescent protein; Human umbillical vein endothelial cell; Ischemia reperfusion injury; Protein transduction

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CELL PENETRATING PEPTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; NICKEL; PROTEIN PEP 1; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PLASMID; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REPERFUSION INJURY; UMBILICAL VEIN;

CELLS, CULTURED; CYSTEAMINE; ENDOTHELIAL CELLS; GREEN FLUORESCENT PROTEINS; HUMANS; PEPTIDES; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; UMBILICAL VEINS;

EID: 33947203683     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, et al. Ischemia/ reperfusion injury [J]. J Surg Res, 2002, 105 (2):248-258.
2. Morris MC, Depollier J, Mery J, et al. A pepfide carrier for the delivery of biologically active proteins into mammalian cells [J]. Nat Biotechnol, 2001, 19(12):1173-1176.
3. Chinese source.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding [J]. Anal Biochem, 1976, 72:248-254.
5. Trehin R, Merkle HP. Chances and pitfalls of cell penetrating peptides for cellular drug delivery [J]. Eur J Pharm Biopharm, 2004, 58(2):209-223.
6. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein [J]. Cell, 1988, 55(6):1179-1188.
7. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus [J]. Cell, 1988, 55 (6):1189-1193.
8. Zhang W, Smith SO. Mechanism of penetration of Antp (43-58) into membrane bilayers [J]. Biochemistry, 2005, 44(30):10110-10118.
9. Normand N, van Leeuwen H, O'Hare P. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery [J]. J Biol Chem, 2001, 276(18):15042-15050.
10. Snyder EL, Meade BR, Dowdy SF. Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function [J]. J Control Release, 2003, 91(1-2):45-51.
11. Park J, Ryu J, Kim KA, et al. Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells [J]. J Gen Virol, 2002, 83(Pt5): 1173-1181.
12. Zender L, Kuhnel F, Kock R, et al. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo [J]. Cancer Gene Ther, 2002, 9(6):489-496.
13. Kim DW, Eum WS, Jang SH, et al. Transduced Tat-SOD fusion protein protects against ischemic brain injury [J]. Mol Cells, 2005, 19(1):88-96.
14. Jin LH, Bahn JH, Eum WS, et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells [J]. Free Radic Biol Med, 2001, 31(11):1509-1519.
15. Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: unrestricted delivery into all cells [J]? Trends Cell Biol, 2000, 10(7):290-295.
16. Hashimoto Y, Itoh K, Nishida K, et al. Rapid superoxide production by endothelial cells and their injury upon reperfusion [J]. J Surg Res, 1994, 57(6):693-697.